Another animal study demonstrated that inhibition of the VEGF signaling cascade by blocking VEGFR2 via antibodies results in reduced levels of NO and the development of hypertension, thereby providing a possible explanation for the TKI-induced hypertension [37]. This evidence concerns the gene VEGFA and hypertensive disorder.